Cite
MLA Citation
Julie R. Brahmer et al.. “Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non–Small-Cell Lung Cancer in CheckMate 227.” Journal of clinical oncology, vol. 41, no. 6, 2023, pp. 1200–1212. http://access.bl.uk/ark:/81055/vdc_100179398088.0x00002b